GL1X · GenesisL1 explorer

Research workbench

Oxa-48 carbapanemase, apo form

Analyse Oxa-48 carbapanemase, apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6P96
Type
protein
Length
486 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q6XEC0
Ligands
CA, CD, CL
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase (EC 3.5.2.6)protein24341% helix, 21% strandQ6XEC0

Ligands and binding sites

  • CA · Calcium ion · metal · 3 copies · chains A, B
  • CD · Cadmium ion · metal · 2 copies · chains A
  • CL · Chloride ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19180.780.81122CL
2710.400.7918empty
3620.370.7916empty

Interfaces

1 interface between chains.

  • A–B · 1011 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 6P96 · OXA-48 carbapanemase, apo form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.